Cosmos Health (NASDAQ:COSM – Get Free Report) and Jupiter Neurosciences (NASDAQ:JUNS – Get Free Report) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, profitability, institutional ownership, analyst recommendations, dividends and earnings.
Insider & Institutional Ownership
12.6% of Cosmos Health shares are owned by institutional investors. 25.1% of Cosmos Health shares are owned by insiders. Comparatively, 50.8% of Jupiter Neurosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Earnings and Valuation
This table compares Cosmos Health and Jupiter Neurosciences”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Cosmos Health | $65.27 million | 0.28 | -$19.15 million | ($0.61) | -0.59 |
| Jupiter Neurosciences | $20,000.00 | 657.76 | -$8.65 million | ($0.26) | -1.39 |
Jupiter Neurosciences has lower revenue, but higher earnings than Cosmos Health. Jupiter Neurosciences is trading at a lower price-to-earnings ratio than Cosmos Health, indicating that it is currently the more affordable of the two stocks.
Analyst Recommendations
This is a breakdown of recent ratings and target prices for Cosmos Health and Jupiter Neurosciences, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Cosmos Health | 1 | 0 | 0 | 0 | 1.00 |
| Jupiter Neurosciences | 1 | 0 | 0 | 0 | 1.00 |
Volatility and Risk
Cosmos Health has a beta of 5.33, indicating that its share price is 433% more volatile than the S&P 500. Comparatively, Jupiter Neurosciences has a beta of 2.8, indicating that its share price is 180% more volatile than the S&P 500.
Profitability
This table compares Cosmos Health and Jupiter Neurosciences’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Cosmos Health | -29.33% | -43.96% | -16.22% |
| Jupiter Neurosciences | N/A | -1,314.62% | -202.57% |
Summary
Cosmos Health beats Jupiter Neurosciences on 6 of the 11 factors compared between the two stocks.
About Cosmos Health
Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.
About Jupiter Neurosciences
Jupiter Neurosciences, Inc., a clinical stage research and development pharmaceutical company, develops resveratrol platform product primarily for the treatment of neuro-inflammation. It is developing JNS101 that is in Phase II trials for the treatment of Friedreich's Ataxia, a rare disease that causes damage to the nervous system, as well as mobility dysfunctions; and JNS102, which is in Phase II trials for the treatment of mucopolysaccharidosis Type I. The company is also developing JNS107 that is in Phase II trials for the treatment of MELAS Syndrome; and JNS108, which is in Phase II trials for the treatment of mild cognitive impairment/early Alzheimer's disease. In addition, it is developing JNS109 for amyotrophic lateral sclerosis; JNS110 for traumatic brain injury/concussion; and JNS120 for covid-19 treatment. The company was formerly known as Jupiter Orphan Therapeutics, Inc. and changed its name to Jupiter Neurosciences, Inc. in August 2021. The company was founded in 2016 and is headquartered in Jupiter, Florida.
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.
